查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1976687

医疗资产管理市场：依医疗设备、资讯科技基础设施、设施管理、药品和实验室设备划分－2026-2032年全球预测

Healthcare Asset Management Market by Medical Equipment, Information Technology Infrastructure, Facilities Management, Pharmaceuticals, Laboratory Instruments - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，医疗保健资产管理市场价值将达到 393.8 亿美元，到 2026 年将成长至 428 亿美元，到 2032 年将达到 776.1 亿美元，复合年增长率为 10.17%。

主要市场统计数据
基准年 2025 393.8亿美元
预计年份：2026年 428亿美元
预测年份 2032 776.1亿美元
复合年增长率 (%) 10.17%

医疗资产管理正经历一场策略转型，其驱动力来自多面向因素，包括技术加速应用、监管力度加大以及现有资本投资价值最大化的需求。管理影像设备、诊断仪器、药品、 IT基础设施和设施系统等各类资产的机构面临双重挑战：既要维持临床营运的连续性，又要整合新的数位化功能，以实现更有效率的预测性维护、远端监控和使用情况追踪。

随着医院和综合医疗网络将韧性置于优先地位，它们正将工作重点从被动维护转向基于生命週期的资产管治。这种转变体现在对资产标籤、集中式资料平台以及整合采购、临床工程和财务团队的成熟管治流程的投资。这些变革并非自愿，而是风险管理、实现临床品质指标和控制营运成本的必要要素。此外，策略观点如今已超越单一资产，涵盖设备生态系统、软体生态系统和设施网路。这种全面的观点需要跨学科合作以及清晰的技术应用和人才培养蓝图。

数位化、不断变化的法规、网路安全和人才动态都在汇聚，重新定义医疗保健资产管理的优先事项和营运模式。

医疗资产管理格局正在发生变化，这既带来了机会，也带来了风险。数位化转型是其中最显着的驱动力。连网影像设备、具备分析功能的资产管理软体以及云端託管的IT基础设施正在改变医疗机构监控资产状态和分配资源的方式。这个数位化层面实现了远距离诊断和预测性维护，但同时也扩大了网路安全威胁的攻击面，并增加了透过临床工程和IT安全部门之间的协作进行风险管理的必要性。

对 2025 年关税措施将如何重塑整个医疗保健资产组合的采购经济、备件策略和供应商本地化决策进行全面评估。

2025年实施的新关税措施为医疗资产管理者在成本、供应链和策略采购方面带来了复杂的挑战。这些关税措施影响成品医疗设备和中间组件，改变了影像设备、伺服器、网路设备、侦测设备以及某些药品原料的采购经济性。采购团队现在需要权衡短期成本影响与供应商多元化、近岸外包和长期服务合约等策略优势，这些措施可以保护机构免受关税短期波动的影响。

明确医疗资产管理中的细分级别：使设备类型、 IT基础设施、设施系统、药品和实验室设备与营运优先顺序保持一致。

了解资产细分对于制定有针对性的资产管理策略至关重要，因为不同类型的资产在营运、维护和监管方面各有不同。以医疗设备为例，市场可细分为影像设备、病患监测系统及手术器材。影像设备可进一步细分为CT扫描仪及核磁共振造影系统，手术器械则可细分为一般手术器械及微创手术器械。每个细分市场都需要专门的维护通讯协定、校准週期和临床使用规则。以资讯科技基础设施为例，市场可细分为硬体、服务和软体。硬体可再细分为网路设备和伺服器，软体则可细分为分析软体和资产管理软体。这些细分有助于确定本地部署和云端部署模式、修补程式更新频率以及整合优先顺序。

区域策略考量对资产管理的影响反映了全球市场供应链、管理体制和技术采用模式的多样性。

区域环境影响资产策略，因为供应链、管理体制和临床医生工作流程因地区而异。在美洲，采购週期和报销结构往往优先考虑快速采用先进的影像和监控技术，因此重点在于整合、运作保证和灵活的资金筹措。在欧洲、中东和非洲，监管协调、市场成熟度差异以及基础设施的多样性，催生了对模组化解决方案和多层服务模式的需求，这些方案和模式既适用于都市区三级医疗中心，也适用于农村医疗机构。在亚太地区，数位平台的快速普及、医院容量的扩张以及本地生产能力的提升，正在加速对互联IT基础设施和设施自动化的投资。

供应商的产品蓝图、服务模式和管治实务如何决定医疗保健资产组合的长期价值和可靠性。

主要企业透过产品蓝图、服务模式和伙伴关係方式塑造资产管理生态系统，进而影响供应商的选择。那些能够整合强大的远距离诊断功能、提供标准化互通性框架并承诺透明的生命週期支援合约的供应商，对于那些寻求在最大限度减少停机时间的同时获取营运智慧的医疗系统而言，无疑是理想的策略合作伙伴。同样重要的是，那些能够将技术维护和分析能力相结合，从而实现预测性维护计划的服务供应商，这有助于提高设备可用性并有效利用临床资源。

采取切实可行、影响深远的领导行动，整合管治、采购、技术和人才策略，以增强医疗保健资产的韧性和价值。

行业领导者必须将洞察转化为可执行的步骤，以增强韧性并优化资产绩效。首先，企业应采用生命週期管治模型，并利用统一的指标管理运转率、使用率和合规性。此模型规范了资产标籤、文件和交接流程，确保在所有权变更和服务合约过渡期间的责任落实和资料完整性。

调查方法结合了现场访谈、技术文件和基于情境的供应链分析，以得出实用且检验的资产管理见解。

本研究整合了定性和定量数据，以得出平衡且实用的见解。主要资料来源包括对临床技术人员、采购经理、医院高阶主管和供应商服务经理的访谈，旨在收集有关维护实务、备件物流和供应商绩效的实际观点。辅助资讯来源包括官方监管文件、医疗设备和IT系统技术标准、产业白皮书以及展示实施成果的案例研究。对主要和辅助资讯的交叉检验确保了结论既反映了实际情况，又符合既定标准。

一项强调生命週期管治、互操作系统和供应链弹性的全面分析，确保了医疗保健的连续性和营运绩效。

总之，医疗资产管理正处于策略转折点，技术创新、监管变革和供应链动态相互交织，重新定义了营运重点。未来发展需要各机构从各自独立的维护实务转向以生命週期为中心的管治，采用互通性的技术实现预测性奖励，并实施使供应商激励机制与临床可用性一致的筹资策略。关税相关的波动凸显了多元化供应策略和透明的供应商合约对于保障医疗服务连续性的重要性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：医疗设备器材市场

  • 医疗影像设备
    • 电脑断层扫描器（CT扫描仪）
    • 磁振造影（核磁共振造影系统）机
  • 病患监测系统
  • 手术器械
    • 一般外科器械
    • 微创手术器械

第九章：资讯科技基础设施驱动的医疗保健资产管理市场

  • 硬体
    • 网路装置
    • 伺服器
  • 服务
  • 软体
    • 分析软体
    • 资产管理软体

第十章：按设施管理系统分類的医疗保健资产管理市场

  • 建筑自动化
    • 空调系统
    • 照明控制系统
  • 家政
  • 安全系统
    • 门禁系统
    • 监控系统

第十一章：按药品类型分類的医疗保健资产管理市场

  • 生物製药
    • 单株抗体
    • 重组蛋白
  • 品牌药品
    • 循环系统药物
    • 抗癌药物
  • 学名药

第十二章：按实验室设备分類的医疗保健资产管理市场

  • 分析设备
    • 层析法系统
    • 光谱分析仪
  • 生命科学设备
    • 细胞分析仪
    • PCR系统

第十三章 医疗保健资产管理市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 医疗保健资产管理市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 医疗保健资产管理市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国医疗保健资产管理市场

第十七章：中国医疗资产管理市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Accruent, LLC
  • Baxter International Inc.
  • Cardinal Health, Inc.
  • GE HealthCare Technologies Inc.
  • International Business Machines Corporation
  • Koninklijke Philips NV
  • McKesson Corporation
  • Oracle Corporation
  • Securitas Healthcare, LLC
  • Sepio Inc.
  • Siemens Healthineers AG
  • Sonitor Technologies
  • SPM Assets by Planon Corporation
  • Vizzia Technologies
  • Zebra Technologies Corp.
Product Code: MRR-69324464D212

The Healthcare Asset Management Market was valued at USD 39.38 billion in 2025 and is projected to grow to USD 42.80 billion in 2026, with a CAGR of 10.17%, reaching USD 77.61 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 39.38 billion
Estimated Year [2026] USD 42.80 billion
Forecast Year [2032] USD 77.61 billion
CAGR (%) 10.17%

Healthcare asset management is undergoing a strategic reorientation driven by simultaneous pressures: accelerating technology adoption, heightened regulatory scrutiny, and the imperative to extract greater value from existing capital investments. Organizations that manage portfolios spanning imaging devices, laboratory instruments, pharmaceuticals, IT infrastructure, and facility systems are confronted with the dual challenge of sustaining uninterrupted clinical operations while integrating new digital capabilities that promise predictive maintenance, remote monitoring, and improved utilization tracking.

As hospitals and integrated delivery networks prioritize resilience, they are reallocating attention from reactive maintenance to lifecycle-based asset governance. This shift manifests through investments in asset tagging, centralized data platforms, and mature governance processes that align procurement, clinical engineering, and finance teams. These changes are not optional; rather, they are essential to manage risk, meet clinical quality metrics, and control operational costs. Moreover, the strategic lens now extends beyond individual assets to encompass networks of devices, software ecosystems, and facilities - a holistic view that requires cross-disciplinary collaboration and a clear roadmap for technology adoption and workforce development.

How digitalization, regulatory evolution, cybersecurity and workforce dynamics are jointly redefining priorities and operating models in healthcare asset management

The landscape of healthcare asset management is shifting in ways that reconfigure both opportunity and risk. Digital transformation is the most visible force: internet-connected imaging equipment, analytics-enabled asset management software, and cloud-hosted IT infrastructure are changing how organizations monitor asset health and allocate resources. This digital layer enables remote diagnostics and predictive maintenance, yet it also increases the attack surface for cybersecurity threats, intensifying the need for coordinated risk management across clinical engineering and IT security functions.

Concurrently, regulatory and compliance frameworks are evolving to reflect patient safety concerns and data privacy imperatives. Stricter standards for device interoperability, software validation, and supply chain transparency compel providers to document provenance and lifecycle events for critical assets. At the same time, workforce dynamics - including shortages in skilled biomedical technicians and new expectations for data literacy among frontline staff - are reshaping operational models. These transformative shifts require leaders to prioritize cross-functional training, invest in interoperable systems, and adopt rigorous vendor governance practices to ensure that technological gains translate into measurable improvements in uptime, patient safety, and fiscal stewardship.

Comprehensive assessment of how 2025 tariff actions are reshaping procurement economics, spare parts strategies and supplier localization decisions across healthcare assets

The introduction of new tariff measures in 2025 has created a complex overlay of cost, supply chain, and strategic sourcing considerations for healthcare asset managers. Tariffs affect both finished medical goods and intermediate components, altering procurement economics for imaging equipment, servers, networking hardware, laboratory instruments, and certain pharmaceutical inputs. Procurement teams must now weigh the immediate cost implications against the strategic benefits of supplier diversification, nearshoring, and long-term service agreements that insulate organizations from episodic tariff volatility.

Beyond procurement, tariffs have second-order effects on maintenance strategies and spare parts inventories. Facilities and clinical engineering departments are adjusting stocking policies to maintain clinical availability while avoiding excessive capital tied up in parts that risk obsolescence. In parallel, vendors are responding by revising distribution footprints, renegotiating service-level commitments, and localizing certain manufacturing processes. These responses create opportunities for healthcare organizations to renegotiate total-cost-of-ownership terms and to demand greater transparency in lifecycle support. Ultimately, asset managers must incorporate tariff scenarios into capital planning and vendor selection processes, ensuring continuity of care while preserving fiscal discipline and supplier accountability.

Segment-level clarity for healthcare asset management that aligns device types, IT infrastructure, facility systems, pharmaceuticals and laboratory equipment with operational priorities

Understanding segmentation is essential for targeted asset management strategies because assets exhibit distinct operational, maintenance, and regulatory profiles. Based on Medical Equipment, the market is studied across Imaging Equipment, Patient Monitoring Systems, and Surgical Instruments, with Imaging Equipment further examined through Computed Tomography Scanners and Magnetic Resonance Imaging Machines, and Surgical Instruments differentiated into General Surgical Instruments and Minimally Invasive Instruments; each subset requires tailored maintenance protocols, calibration cycles, and clinical utilization rules. Based on Information Technology Infrastructure, the market is studied across Hardware, Services, and Software, with Hardware further divided into Networking Equipment and Servers, and Software segmented into Analytics Software and Asset Management Software; these distinctions inform decisions about on-premises versus cloud deployments, patching cadences, and integration priorities.

In Facilities Management, the market is studied across Building Automation, Housekeeping, and Security Systems, with Building Automation further studied across HVAC Systems and Lighting Control Systems, and Security Systems distinguished into Access Control Systems and Surveillance Systems; these categories drive energy management initiatives and influence patient flow and safety protocols. Based on Pharmaceuticals, the market is studied across Biopharmaceuticals, Branded Drugs, and Generic Drugs, with Biopharmaceuticals further analyzed as Monoclonal Antibodies and Recombinant Proteins, and Branded Drugs examined through Cardiovascular Drugs and Oncology Drugs; pharmaceutical segmentation affects cold chain logistics, inventory turnover policies, and regulatory documentation. Based on Laboratory Instruments, the market is studied across Analytical Instruments and Life Science Instruments, with Analytical Instruments subdivided into Chromatography Systems and Spectroscopy Instruments, and Life Science Instruments including Cell Analysis Instruments and PCR Systems; laboratory segmentation determines calibration requirements, consumables planning, and biosafety considerations.

Recognizing these discrete segments enables asset managers to prioritize interventions that balance clinical impact, lifecycle costs, and regulatory compliance. It also facilitates procurement strategies that align vendor capabilities with specific asset-class requirements, thereby improving service reliability and reducing downstream operational friction.

Regional strategic considerations for asset management that reflect supply chain diversity, regulatory regimes and technology adoption patterns across global markets

Regional context shapes asset strategies because supply chains, regulatory regimes, and clinician workflows vary significantly across geographies. In the Americas, procurement cycles and reimbursement structures often prioritize rapid deployment of advanced imaging and monitoring technologies, which drives a focus on integration, uptime guarantees, and flexible financing. In Europe, Middle East & Africa, regulatory harmonization, diverse market maturities, and infrastructure variability create demand for modular solutions and multi-tiered service models that can be adapted to both urban tertiary centers and rural facilities. In Asia-Pacific, rapid adoption of digital platforms, expanding hospital capacity, and localized manufacturing capacities are accelerating investments in interconnected IT infrastructure and facility automation.

These regional distinctions mean that a one-size-fits-all approach to asset management is ineffective. Instead, organizations should adopt regionally differentiated procurement playbooks that account for vendor footprints, regulatory timelines, and the availability of technical talent. Moreover, capital planners should incorporate regional risk assessments - including political, trade, and logistical considerations - to ensure resilience. Ultimately, regional insights should inform vendor selection, spare parts strategies, and training programs so that the right mix of local support and centralized governance delivers consistent patient outcomes across diverse settings.

How vendor product roadmaps, service models and governance practices determine long-term value and reliability in healthcare asset portfolios

Key companies shape the asset management ecosystem through product roadmaps, service models, and partnership approaches that influence provider choices. Vendors that integrate robust remote diagnostics, offer standardized interoperability frameworks, and commit to transparent lifecycle support agreements stand out as strategic partners for healthcare systems aiming to minimize downtime while capturing operational intelligence. Equally important are service providers that can couple technical maintenance with analytics capabilities, enabling predictive maintenance programs that translate into higher equipment availability and more efficient utilization of clinical capacity.

In addition to product and service capabilities, vendor governance matters. Organizations should evaluate suppliers on criteria such as spare parts logistics, firmware and software update cadences, cybersecurity practices, and the availability of accredited field service engineers. Collaboration with vendors on data-sharing agreements and performance-based contracts can align incentives toward improved uptime and reduced total cost of care. Finally, companies that demonstrate commitment to workforce enablement and knowledge transfer - through training, certification, and remote support - will be better positioned to support long-term operational resilience and technology adoption across complex asset portfolios.

Practical, high-impact actions for leaders to align governance, procurement, technology and workforce strategies to strengthen healthcare asset resilience and value

Industry leaders must translate insights into executable actions that strengthen resilience and optimize asset performance. First, organizations should adopt a lifecycle governance model that integrates procurement, clinical engineering, finance, and IT under unified metrics for uptime, utilization, and compliance. This governance model should standardize asset tagging, documentation, and handoff processes so that accountability and data integrity persist across ownership changes and service contracts.

Second, leaders should prioritize investments in interoperable asset management software and analytics platforms that provide a single pane of glass for device health, maintenance scheduling, and spare parts forecasting. Such platforms enable predictive programs and reduce reactive maintenance workloads. Third, procurement strategies should shift toward total-cost-of-ownership contracts that include clear performance guarantees, defined spare parts availability, and penalties or credits tied to service outcomes. Fourth, workforce strategies must address technician shortages by investing in remote support capabilities, cross-training, and strategic partnerships with vendors for field service augmentation. Finally, leaders should incorporate geopolitical and tariff risk assessments into capital planning, diversifying suppliers and evaluating nearshoring options to preserve continuity of care while maintaining fiscal discipline.

Methodological approach that integrates frontline interviews, technical documentation and scenario-based supply chain analysis to produce practical and verifiable asset management insights

This research synthesizes qualitative and quantitative inputs to ensure balanced, actionable findings. Primary inputs include interviews with clinical engineers, procurement leaders, hospital operations executives, and vendor service managers to capture frontline perspectives on maintenance practices, spare parts logistics, and vendor performance. Secondary inputs comprise public regulatory documents, technical standards for medical devices and IT systems, industry white papers, and case studies demonstrating deployment outcomes. Cross-validation between primary and secondary sources ensures that conclusions reflect both lived operational realities and established standards.

Analytical methods emphasize triangulation and scenario analysis rather than predictive modeling. Asset-class analyses draw on device technical manuals, service-level agreements, and real-world service logs to identify common failure modes, maintenance cadences, and the interplay between software updates and device availability. For regional and tariff impact assessments, supply chain mapping and supplier footprint analysis were conducted to illustrate likely operational responses without relying on market sizing estimates. The methodology favors transparent assumptions, clearly documented data sources, and sensitivity checks to ensure that recommendations remain robust under varying operational conditions.

Concluding synthesis emphasizing lifecycle governance, interoperable systems and supply chain resilience to secure continuity of care and operational performance

In conclusion, healthcare asset management is at a strategic inflection point where technology, regulatory change, and supply chain dynamics converge to redefine operational priorities. The path forward requires organizations to move from siloed maintenance practices to lifecycle-centered governance, to adopt interoperable technologies that enable predictive maintenance, and to implement procurement strategies that align vendor incentives with clinical availability. Tariff-related disruptions underscore the importance of diversified supply strategies and transparent vendor agreements that protect continuity of care.

Leaders who act decisively will secure reliable clinical operations and extract greater value from existing assets by combining robust governance, targeted technology investments, and adaptive procurement practices. Sustained improvements will depend on collaborative relationships across clinical engineering, IT, procurement, and supplier partners, supported by consistent data practices and workforce development. By following the recommendations and frameworks presented in this report, organizations can strengthen readiness for emerging risks and capitalize on opportunities to enhance patient outcomes and operational efficiency.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Healthcare Asset Management Market, by Medical Equipment

  • 8.1. Imaging Equipment
    • 8.1.1. Computed Tomography Scanners
    • 8.1.2. Magnetic Resonance Imaging Machines
  • 8.2. Patient Monitoring Systems
  • 8.3. Surgical Instruments
    • 8.3.1. General Surgical Instruments
    • 8.3.2. Minimally Invasive Instruments

9. Healthcare Asset Management Market, by Information Technology Infrastructure

  • 9.1. Hardware
    • 9.1.1. Networking Equipment
    • 9.1.2. Servers
  • 9.2. Services
  • 9.3. Software
    • 9.3.1. Analytics Software
    • 9.3.2. Asset Management Software

10. Healthcare Asset Management Market, by Facilities Management

  • 10.1. Building Automation
    • 10.1.1. HVAC Systems
    • 10.1.2. Lighting Control Systems
  • 10.2. Housekeeping
  • 10.3. Security Systems
    • 10.3.1. Access Control Systems
    • 10.3.2. Surveillance Systems

11. Healthcare Asset Management Market, by Pharmaceuticals

  • 11.1. Biopharmaceuticals
    • 11.1.1. Monoclonal Antibodies
    • 11.1.2. Recombinant Proteins
  • 11.2. Branded Drugs
    • 11.2.1. Cardiovascular Drugs
    • 11.2.2. Oncology Drugs
  • 11.3. Generic Drugs

12. Healthcare Asset Management Market, by Laboratory Instruments

  • 12.1. Analytical Instruments
    • 12.1.1. Chromatography Systems
    • 12.1.2. Spectroscopy Instruments
  • 12.2. Life Science Instruments
    • 12.2.1. Cell Analysis Instruments
    • 12.2.2. PCR Systems

13. Healthcare Asset Management Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Healthcare Asset Management Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Healthcare Asset Management Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Healthcare Asset Management Market

17. China Healthcare Asset Management Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Accruent, LLC
  • 18.7. Baxter International Inc.
  • 18.8. Cardinal Health, Inc.
  • 18.9. GE HealthCare Technologies Inc.
  • 18.10. International Business Machines Corporation
  • 18.11. Koninklijke Philips N.V.
  • 18.12. McKesson Corporation
  • 18.13. Oracle Corporation
  • 18.14. Securitas Healthcare, LLC
  • 18.15. Sepio Inc.
  • 18.16. Siemens Healthineers AG
  • 18.17. Sonitor Technologies
  • 18.18. SPM Assets by Planon Corporation
  • 18.19. Vizzia Technologies
  • 18.20. Zebra Technologies Corp.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES HEALTHCARE ASSET MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY SCANNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PATIENT MONITORING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PATIENT MONITORING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PATIENT MONITORING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERAL SURGICAL INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERAL SURGICAL INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERAL SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MINIMALLY INVASIVE INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MINIMALLY INVASIVE INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MINIMALLY INVASIVE INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY NETWORKING EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY NETWORKING EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY NETWORKING EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ASSET MANAGEMENT SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ASSET MANAGEMENT SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ASSET MANAGEMENT SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HVAC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HVAC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HVAC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIGHTING CONTROL SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIGHTING CONTROL SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIGHTING CONTROL SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HOUSEKEEPING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HOUSEKEEPING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HOUSEKEEPING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ACCESS CONTROL SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ACCESS CONTROL SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ACCESS CONTROL SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURVEILLANCE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURVEILLANCE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURVEILLANCE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ONCOLOGY DRUGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ONCOLOGY DRUGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ONCOLOGY DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERIC DRUGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERIC DRUGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERIC DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CELL ANALYSIS INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CELL ANALYSIS INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CELL ANALYSIS INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PCR SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PCR SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 248. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 265. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 266. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 267. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 268. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 269. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 270. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 271. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 272. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 273. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 274. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 275. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 276. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 277. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2018-2032 (USD MILLION)
  • TABLE 278. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 279. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 280. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPEAN UNION HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPEAN UNION HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIO